Pinz Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25,500	Closed	-$1.55M	–	162
2019 Q4	$1.55M	Buy	+25,500	New	+$1.55M	0.57%	96